Vir Biotechnology, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (5)

Latest Posts

About This Stock More About This Stock
E Aggressive Reddit Short Squeeze Activity Still At Play
Article By: Lorimer Wilson
Sunday, February 28, 2021 3:00 AM EST
Those stocks with +30% short interests declined 3.8%, on average, last week. This article takes a look at the short interest stock activity this past week and their performances since mid-January when the aggressive short squeeze activity began.
In this article: GME, SKT, AMCX, ZYXI, OTRX, KOSS, FIZZ, AXDX, SRG, FLGT, VIR
Read
E Is It Game Over For GameStop And Other High Short Interest Stocks?
Article By: Lorimer Wilson
Sunday, February 21, 2021 1:59 PM EST
The 29 Reddit stocks with short interests in excess of 30% have declined 8.9%, on average, in the past week. So is the short squeeze in these stocks over?
In this article: C, MAC, ZYXI, CLVS, NAKD Also: GME, M, SKT, AMCX, FIZZ, SPWR, BYND, VIR
Read
Weekly Commentary: The Great 2021 Squeeze Mania
Article By: Doug Noland
Sunday, January 31, 2021 8:30 AM EST
Yet another week for the history books. For posterity: GameStop gained 400%, AMC Entertainment 278%, Express 235%, Siebert Financial 122%, Cel-Sci 75%, Novavax 74%, Vaxart 68%, Fulgent Genetics 60%, Vir Biotech 59%, National Bev 54%, and Fossil 47%.
In this article: GME Also: EXPR, CVM, NVAX, QQQ, SIEB, FIZZ, FOSL, VIX, AMC, FLGT, VIR, VXRT
Read
The Week Ahead In Biotech: Merck, Pfizer In Earnings Mix, Plus Adamas, Mallinckrodt FDA Decisions, IPOs, And More
Article By: Benzinga
Saturday, January 30, 2021 2:57 PM EST
Biotech stocks alternated between gains and losses in the week ended Jan. 29 before ending lower. Big pharma earnings season kick started, with Novartis AG, Johnson & Johnson, and Eli Lilly And Co all in the mix.
In this article: JNJ, LLY, MRK, NVS, NVAX, BIIB, TPTX, ADMS, VIR, VXRT
Read
Biopharma Leads Healthcare Portfolio 2020-2021
Article By: Rod Raynovich
Tuesday, January 19, 2021 1:47 PM EST
Clearly, biopharma stocks, both large and small, led the way to outperformance within healthcare. But Q4 2020 was very speculative, so we expect that the momentum will ebb in 2021 in a shift to large-caps.
In this article: AZN, MRK, GNMK, GILD, IHE, IWM, MRNA, TDOC, VIR, XBI
Read

Latest Tweets for $VIR

No tweets yet!